Global Cardiac Safety Services Market Expected to Reach USD 20 Billion By 2026

03-Mar-2020 | Facts and Factors

Findings from Facts and Factors report “Cardiac Safety Services Market By Type (Standalone Services and Integrated Services), By Type of Services (ECG/Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Study, and Others), By End-User (Pharmaceutical & Biopharmaceutical Companies and Contract Research Organizations), and By Region: Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026” states that the global Cardiac Safety Services market in 2019 was approximately USD 441 Billion. The market is expected to grow at a CAGR of 11.8% and is anticipated to reach around USD 840 Billion by 2026.

Cardiac safety problems are one of the leading reasons behind drug withdrawal in the market. It is thus mandatory for regulatory submissions of new drugs to demonstrate a performance of an appropriate cardiac safety assessment. For understanding the cardiac risks of new drugs during the early stage of the development process, the Spaulding Cardiac Solutions are performed with the help of industry experts andrenowned cardiologist. The global Cardiac Safety Services market helps build a strong cardiac safety profile for the development of a safe drug.

Browse the full “Cardiac Safety Services Market By Type (Standalone Services and Integrated Services), By Type of Services (ECG/Holter Measurement, Blood Pressure Measurement, Cardiovascular Imaging, Thorough QT Study, and Others), By End-User (Pharmaceutical & Biopharmaceutical Companies and Contract Research Organizations), and By Region: Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026" report at https://www.fnfresearch.com/global-cardiac-safety-services-market-by-type-standalone-589

Market Drivers:

The primary factors propelling the growth of the global Cardiac Safety Services market is the growth in the spending on healthcare and advancements in the R&D activities taking place in the pharmaceutical & biopharmaceutical commerce. In addition, the mounting number of clinical trials is also expected to bolster the growth of the market during the forecast period. The development of novel technologies &approachesplus the evolution in the biosimilars and biologics market will offer immense growth opportunities for players working in the global Cardiac Safety Services market.

Market Segment Dominance:

• Integrated services category is projected to dominate the global Cardiac Safety Services market

The integrated services category is expected to lead the global Cardiac Safety Services market owing to the benefits of numerous services to manage end-to-end improvements.

• Pharmaceutical & biopharmaceutical companies category is estimated to lead the global Cardiac Safety Services market

In the global Cardiac Safety Services market, the pharmaceutical & biopharmaceutical companies category is anticipated to exhibit the highest market valuation owing to factors such as the harsh government regulations for drug safety and the surging R&D activities for improving high-quality and new drugs.

Regional Dominance:

• North America is anticipated to hold the majority of the market share in the global Cardiac Safety Services market

North America is likely to hold the major market share of the global Cardiac Safety Services market owing to the increasing demand for pharmaceutical & biopharmaceutical firms in the region. In addition to this, the rising number of cardiac problems among the growing population has urged the performance of a number of clinical trials in the region.

Report Scope

Key Market Players:

Some of the key players of the global Cardiac Safety Services market are Banook Group, Biotrial, PhysioStim, ERT, Inc., Bioclinica, Medpace Holdings, Inc., Ncardia AG, BioTelemetry, Inc., Celerion, Inc., Certara L.P., Laboratory Corporation of America Holdings, Richmond Pharmacology, Pharmaceutical Product Development LLC, Shanghai Medicilon Inc., SGS S.A., and IQVIA.

This report segments the Cardiac Safety Services market as follows:

Global Cardiac Safety Services Market: Type of Service Segmentation Analysis

• ECG/Holter Measurement
• Blood Pressure Measurement
• Cardiovascular Imaging
• Thorough QT Studies
• Others

Global Cardiac Safety Services Market: Type Segmentation Analysis

• Integrated Services
• Standalone Services

Global Cardiac Safety Services Market: End User Segmentation Analysis

• Pharmaceutical & Biopharmaceutical Companies
• Contract Research Organizations

Global Cardiac Safety Services Market: Regional Segmentation Analysis

• North America
  • The U.S.
  • Canada
• Europe
  • Germany
  • The UK
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Contact Us:

Facts & Factors

Global Headquarters

Level 8, International Finance Center, Tower 2,
8 Century Avenue, Shanghai,
Postal - 200120, China
Tel: +86 21 80360450

Email: [email protected]

Web: https://www.fnfresearch.com